Assisted autogenic drainage in infants and young children hospitalized with uncomplicated pneumonia, a pilot study

Lieselotte Corten, Jennifer Jelsma, Anri Human, Sameer Rahim, Brenda Morrow

Research output: Contribution to journalArticle

Abstract

Background and purpose: Pneumonia is the most important respiratory problem in low‐to middle income countries. Airway clearance therapy continues to be used in children with pneumonia and secretion retention; however, there is lack of evidence to support or reject this treatment. This study aimed to investigate the feasibility of a randomized controlled trial (RCT) on the efficacy and safety of assisted autogenic drainage (AAD) compared to standard nursing care in children hospitalized with uncomplicated pneumonia.
Methods: A single‐blinded pilot RCT was conducted on 29 children (median age 3.5 months, IQR 1.5–9.4) hospitalized with uncomplicated pneumonia. The intervention group received standard nursing care with additional bi‐daily AAD, for 10 to 30 min. The control group only received standard nursing care, unless otherwise deemed necessary by the physician or physiotherapist. The primary outcome measure was duration of hospitalization. The secondary outcome measures included days of fever and supplemental oxygen support; respiratory rate (RR) and heart rate adjusted for age; RR and oxygen saturation pre‐, post‐, and 1‐hr post‐treatment; oxygen saturation; adverse events; and mortality.
Results: No difference was found for duration of hospitalization (median 7.5 and 7.0 days for the control and intervention groups, respectively); however, Kaplan–Meier analysis revealed a strong tendency towards a shorter time to discharge in the intervention group (p = .06). No significant differences were found for the other outcome measures at time of discharge. No adverse events were
reported.Within the intervention group, a significant reduction in RR adjusted for age was found.
Discussion: As no adverse events were reported, and AAD did not prolong hospitalization; AAD might be considered as safe and effective in young children with uncomplicated pneumonia. However, a larger multicentred RCT is warranted to determine the efficacy of AAD compared to standard nursing care.
Original languageEnglish
Pages (from-to)e1690
JournalPhysiotherapy Research International
Volume23
Issue number1
DOIs
Publication statusPublished - 19 Jul 2017

Fingerprint

Hospitalized Child
Drainage
Pneumonia
Nursing Care
Respiratory Rate
Hospitalization
Randomized Controlled Trials
Outcome Assessment (Health Care)
Oxygen
Control Groups
Physical Therapists
Fever
Heart Rate
Physicians
Safety
Mortality
Therapeutics

Keywords

  • airway clearance therapy
  • Pneumonia
  • Paediatric

Cite this

@article{b960fa21779e4c3f94fc114de77ff750,
title = "Assisted autogenic drainage in infants and young children hospitalized with uncomplicated pneumonia, a pilot study",
abstract = "Background and purpose: Pneumonia is the most important respiratory problem in low‐to middle income countries. Airway clearance therapy continues to be used in children with pneumonia and secretion retention; however, there is lack of evidence to support or reject this treatment. This study aimed to investigate the feasibility of a randomized controlled trial (RCT) on the efficacy and safety of assisted autogenic drainage (AAD) compared to standard nursing care in children hospitalized with uncomplicated pneumonia.Methods: A single‐blinded pilot RCT was conducted on 29 children (median age 3.5 months, IQR 1.5–9.4) hospitalized with uncomplicated pneumonia. The intervention group received standard nursing care with additional bi‐daily AAD, for 10 to 30 min. The control group only received standard nursing care, unless otherwise deemed necessary by the physician or physiotherapist. The primary outcome measure was duration of hospitalization. The secondary outcome measures included days of fever and supplemental oxygen support; respiratory rate (RR) and heart rate adjusted for age; RR and oxygen saturation pre‐, post‐, and 1‐hr post‐treatment; oxygen saturation; adverse events; and mortality.Results: No difference was found for duration of hospitalization (median 7.5 and 7.0 days for the control and intervention groups, respectively); however, Kaplan–Meier analysis revealed a strong tendency towards a shorter time to discharge in the intervention group (p = .06). No significant differences were found for the other outcome measures at time of discharge. No adverse events werereported.Within the intervention group, a significant reduction in RR adjusted for age was found.Discussion: As no adverse events were reported, and AAD did not prolong hospitalization; AAD might be considered as safe and effective in young children with uncomplicated pneumonia. However, a larger multicentred RCT is warranted to determine the efficacy of AAD compared to standard nursing care.",
keywords = "airway clearance therapy, Pneumonia, Paediatric",
author = "Lieselotte Corten and Jennifer Jelsma and Anri Human and Sameer Rahim and Brenda Morrow",
year = "2017",
month = "7",
day = "19",
doi = "10.1002/pri.1690",
language = "English",
volume = "23",
pages = "e1690",
journal = "Physiotherapy Research International",
issn = "1358-2267",
number = "1",

}

Assisted autogenic drainage in infants and young children hospitalized with uncomplicated pneumonia, a pilot study. / Corten, Lieselotte; Jelsma, Jennifer; Human, Anri; Rahim, Sameer ; Morrow, Brenda.

In: Physiotherapy Research International, Vol. 23, No. 1, 19.07.2017, p. e1690.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Assisted autogenic drainage in infants and young children hospitalized with uncomplicated pneumonia, a pilot study

AU - Corten, Lieselotte

AU - Jelsma, Jennifer

AU - Human, Anri

AU - Rahim, Sameer

AU - Morrow, Brenda

PY - 2017/7/19

Y1 - 2017/7/19

N2 - Background and purpose: Pneumonia is the most important respiratory problem in low‐to middle income countries. Airway clearance therapy continues to be used in children with pneumonia and secretion retention; however, there is lack of evidence to support or reject this treatment. This study aimed to investigate the feasibility of a randomized controlled trial (RCT) on the efficacy and safety of assisted autogenic drainage (AAD) compared to standard nursing care in children hospitalized with uncomplicated pneumonia.Methods: A single‐blinded pilot RCT was conducted on 29 children (median age 3.5 months, IQR 1.5–9.4) hospitalized with uncomplicated pneumonia. The intervention group received standard nursing care with additional bi‐daily AAD, for 10 to 30 min. The control group only received standard nursing care, unless otherwise deemed necessary by the physician or physiotherapist. The primary outcome measure was duration of hospitalization. The secondary outcome measures included days of fever and supplemental oxygen support; respiratory rate (RR) and heart rate adjusted for age; RR and oxygen saturation pre‐, post‐, and 1‐hr post‐treatment; oxygen saturation; adverse events; and mortality.Results: No difference was found for duration of hospitalization (median 7.5 and 7.0 days for the control and intervention groups, respectively); however, Kaplan–Meier analysis revealed a strong tendency towards a shorter time to discharge in the intervention group (p = .06). No significant differences were found for the other outcome measures at time of discharge. No adverse events werereported.Within the intervention group, a significant reduction in RR adjusted for age was found.Discussion: As no adverse events were reported, and AAD did not prolong hospitalization; AAD might be considered as safe and effective in young children with uncomplicated pneumonia. However, a larger multicentred RCT is warranted to determine the efficacy of AAD compared to standard nursing care.

AB - Background and purpose: Pneumonia is the most important respiratory problem in low‐to middle income countries. Airway clearance therapy continues to be used in children with pneumonia and secretion retention; however, there is lack of evidence to support or reject this treatment. This study aimed to investigate the feasibility of a randomized controlled trial (RCT) on the efficacy and safety of assisted autogenic drainage (AAD) compared to standard nursing care in children hospitalized with uncomplicated pneumonia.Methods: A single‐blinded pilot RCT was conducted on 29 children (median age 3.5 months, IQR 1.5–9.4) hospitalized with uncomplicated pneumonia. The intervention group received standard nursing care with additional bi‐daily AAD, for 10 to 30 min. The control group only received standard nursing care, unless otherwise deemed necessary by the physician or physiotherapist. The primary outcome measure was duration of hospitalization. The secondary outcome measures included days of fever and supplemental oxygen support; respiratory rate (RR) and heart rate adjusted for age; RR and oxygen saturation pre‐, post‐, and 1‐hr post‐treatment; oxygen saturation; adverse events; and mortality.Results: No difference was found for duration of hospitalization (median 7.5 and 7.0 days for the control and intervention groups, respectively); however, Kaplan–Meier analysis revealed a strong tendency towards a shorter time to discharge in the intervention group (p = .06). No significant differences were found for the other outcome measures at time of discharge. No adverse events werereported.Within the intervention group, a significant reduction in RR adjusted for age was found.Discussion: As no adverse events were reported, and AAD did not prolong hospitalization; AAD might be considered as safe and effective in young children with uncomplicated pneumonia. However, a larger multicentred RCT is warranted to determine the efficacy of AAD compared to standard nursing care.

KW - airway clearance therapy

KW - Pneumonia

KW - Paediatric

U2 - 10.1002/pri.1690

DO - 10.1002/pri.1690

M3 - Article

VL - 23

SP - e1690

JO - Physiotherapy Research International

JF - Physiotherapy Research International

SN - 1358-2267

IS - 1

ER -